why choose us

First received: November 01, 2022

Clinical Trial: Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: HPV-Related Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Study of Vorinostat in Combination With Chemoradiation in Patients With Locally Advanced HPV Negative HNSCC

Brief Summary: The purpose of this study is to learn more about a drug called Vorinostat (an experimental drug) in combination with chemoradiation.The intention of this study is to learn if this drug is safe for the participants and whether this drug with chemoradiation is able to further increase the clinical efficacy of chemoradiation which is approved therapy for your tumor condition.The main question it aims to answer is: How may Vorinostat interact with standard chemotherapy and radiation therapy in head and neck…

Read more